Evidence map›Paper›PMID 35535610›Full record

ArticleJournal of the American Heart Association2022

Incidence and Prognostic Implications of Readmissions Caused by Thrombotic Events After a Heart Failure Hospitalization.

Pulkit Chaudhury, Paulino Alvarez, Madonna Michael, Marwan Saad, G Jay Bishop, Mazen Hanna, Venu Menon, Randall C Starling, Alex C Spyropoulos, Milind Desai and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Pulkit ChaudhuryHeart, Thoracic and Vascular InstituteCleveland Clinic Foundation Cleveland OH.ORCID 0000-0002-8210-8394
Paulino AlvarezHeart, Thoracic and Vascular InstituteCleveland Clinic Foundation Cleveland OH.
Madonna MichaelHeart, Thoracic and Vascular InstituteCleveland Clinic Foundation Cleveland OH.
Marwan SaadDivision of Cardiology Warren Alpert Medical School of Brown UniversityLifespan Cardiovascular Institute Providence RI.ORCID 0000-0002-2280-8030
G Jay BishopHeart, Thoracic and Vascular InstituteCleveland Clinic Foundation Cleveland OH.ORCID 0000-0002-0445-5251
Mazen HannaHeart, Thoracic and Vascular InstituteCleveland Clinic Foundation Cleveland OH.
Venu MenonHeart, Thoracic and Vascular InstituteCleveland Clinic Foundation Cleveland OH.ORCID 0000-0003-4410-2677
Randall C StarlingHeart, Thoracic and Vascular InstituteCleveland Clinic Foundation Cleveland OH.ORCID 0000-0002-1254-4860
Alex C SpyropoulosFeinstein Institutes for Medical Research and The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Hempstead NY.ORCID 0000-0002-3175-461X
Milind DesaiHeart, Thoracic and Vascular InstituteCleveland Clinic Foundation Cleveland OH.ORCID 0000-0003-0010-9797
Amgad MentiasHeart, Thoracic and Vascular InstituteCleveland Clinic Foundation Cleveland OH.ORCID 0000-0001-6555-2517
Cleveland Clinic · USCardiovascular Institute of the South · USNorthwell Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Readmission occurs in 1 out of 3 patients with heart failure (HF). We aimed to study the incidence and prognostic implications of rehospitalizations because of arterial thromboembolism events (ATEs) and venous thromboembolism events (VTEs) after discharge in patients with HF. Methods and Results We identified Medicare beneficiaries who were admitted with a primary diagnosis of HF from 2014 to 2019, with a hospital stay ranging between 3 and10 days, followed by discharge to home. We calculated incidence of ATEs (myocardial infarction, ischemic stroke, or systemic embolism) and VTEs (deep venous thrombosis and pulmonary embolism) up to 90 days after discharge. Out of 2 953 299 patients admitted with HF during the study period, a total of 585 353 patients met the inclusion criteria, and 36.6% were readmitted within 90 days of discharge. The incidence of readmission due ATEs, VTEs, HF, and all other reasons was 3.4%, 0.5%, 13.2%, and 19.5%, respectively. Incidence of thromboembolic events was highest within 14 days after discharge. Factors associated with ATEs included prior coronary, peripheral, or cerebrovascular disease and for VTEs included malignancy and prior liver or lung disease. ATE/VTE readmission had a 30-day mortality of 19.9%. After a median follow-up period of 25.6 months, ATE and VTE readmissions were associated with higher risk of mortality (hazard ratio, 2.76 [95% CI, 2.71-2.81] and 2.17 [95% CI, 2.08-2.27], respectively;

Indexed as

Heart FailureThrombosisVenous ThromboembolismAgedHospitalizationHumansIncidenceMedicarePatient ReadmissionPrognosisRetrospective StudiesRisk FactorsUnited Statesarterial thromboembolismextended thromboprophylaxisheart failurevenous thromboembolism

Identifiers

PMID35535610
PMCPMC9238557
OpenAlexW4280502594

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.